In breast cancer, SIRT6 can enhance the expression and activity of pyruvate dehydrogenase (PDH), thereby enhancing oxidative phosphorylation in breast cancer cells and promoting the occurrence of breast tumors in mice (103). This evidence concerns the gene SIRT6 and breast carcinoma.